Skip to content

MLEC

Moolec Science SA

NASDAQ · Healthcare · Biotechnology · LU

$6.10
−2.09%
Ask drillr
Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open
$6.33
From 52W high
−67.20%
Volume
3687.00
Market cap
$12.69M
P/E (Fwd)
EV/EBITDA
−0.5x
P/E (TTM)
RSI (14)
39.7
1D Return
−2.09%
YTD Return
+60.21%
SummaryUpdated Jun 1, 2025

Moolec Science SA (NASDAQ:MLEC) is a Luxembourg-based biotechnology company founded in 2008 that specializes in producing animal proteins in plants through a technology called Molecular Farming. The company went public in March 2021 and operates across the United States, Europe, and South America. Moolec represents a disruptive approach in the alternative protein landscape, leveraging the natural efficiency of crops like soybeans and peas to produce traditionally animal-derived proteins through genetic engineering techniques.

Similar companies

Latest newsMore news →

No recent news for MLEC.